Citation Impact
Citing Papers
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period
2006
Review of the clinical practice literature on allogeneic red blood cell transfusion
1997
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Heparin-Protein Interactions
2002 Standout
Anemia and Blood Transfusion in Critically Ill Patients
2002 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
2001
Major bleeding after hospitalization for deep-venous thrombosis
1999
Venographic comparison of subcutaneous low–molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
1999
Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease
2001
Cost-Effectiveness of Prolonged Administration of a Low Molecular Weight Heparin for the Prevention of Deep Venous Thrombosis Following Total Hip Replacement
1999
Prognostic Models for Selecting Patients With Acute Pulmonary Embolism for Initial Outpatient Therapy
2007
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Ambulatory management of pulmonary embolism: a pragmatic evaluation
2010
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism
2000
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants
2003
Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis
2012
Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin
2000
Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism
2001
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Comparison of the Efficacy and Safety of Low Molecular Weight Heparins and Unfractionated Heparin in the Initial Treatment of Deep Venous Thrombosis
1996
Costs and Clinical Outcomes Associated With Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Bridging in Patients Receiving Long-term Oral Anticoagulant Therapy
2004
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Medical complications after stroke
1999
Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary Embolism
2000
Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
2001
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1998
Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis
2001
Expanding Eligibility for Outpatient Treatment of Deep Venous Thrombosis and Pulmonary Embolism With Low-Molecular-Weight Heparin
1998
Aortic Aneurysm-Induced Disseminated Intravascular Coagulation
1996
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
1999 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Can Selected Patients With Newly Diagnosed Pulmonary Embolism Be Safely Treated Without Hospitalization? A Systematic Review
2012
Treatment of Deep-Vein Thrombosis
2004
A Clinical Prediction Rule for Identifying Short-Term Risk of Adverse Events in Patients With Pulmonary Thromboembolism
2007
Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis
2005
Economic Evaluation of Enoxaparin as Postdischarge Prophylaxis for Deep Vein Thrombosis (DVT) in Elective Hip Surgery
2000
Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level
2010
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
A Randomized Trial Comparing 2 Low-Molecular-Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism
2005
Home treatment in pulmonary embolism
2009
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Recurrent Venous Thrombosis and Heparin Therapy
1999
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms
2007
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
1997
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
2002
Guidelines on the use and monitoring of heparin
2006
Effectiveness and Economic Impact Associated With a Program for Outpatient Management of Acute Deep Vein Thrombosis in a Group Model Health Maintenance Organization
2000
Heparin-Induced Thrombocytopenia
2006 Standout
Diabetes and Atherosclerosis
2002 Standout
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism
2006
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Medical management of patients with brain tumors
2006
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Malignant Gliomas in Adults
2008 Standout
Use of Low-Molecular-Weight Heparin in the Treatment of Venous Thromboembolic Disease: Answers to Frequently Asked Questions
1998
Heparin and Low-Molecular-Weight Heparin
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis
1999
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis
2005
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
2004
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
2011
Mechanical thrombectomy in patients with deep venous thrombosis
2001
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
2003
Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study
2011
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Disseminated Intravascular Coagulation
1999 Standout
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer
2006
A reduction in Type and Screen: preoperative prediction of RBC transfusions in surgery procedures with intermediate transfusion risks †
2001
Heparin-induced thrombocytopenia is rare in pregnancy
2001
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
2013
Thrombosis in the Emergency Department
1999
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
RBC Transfusion in the ICU
1995
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Evidence from Transgenic Mice That Interferon-β May Be Involved in the Onset of Diabetes Mellitus
1998
Safety of Expedited Anticoagulation in Patients Undergoing Transesophageal Echocardiographic-guided Cardioversion
2006
Hemorrhagic Complications of Anticoagulant Treatment
1998
The worcester venous thromboembolism study
2006
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism
1998
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
2009
Management of Acute Proximal Deep Vein Thrombosis
2002
Efficacy of Unfractionated Heparin, Low Molecular Weight Heparin and Both Combined for Releasing Total and Free Tissue Factor Pathway Inhibitor
1998
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Management of Venous Thromboembolism
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis
1998
An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis
2004
Etiology of stroke in children
2000
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice
1999
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
2001
Clinical Outcome and Cost of Hospital vs Home Treatment of Proximal Deep Vein Thrombosis With a Low-Molecular-Weight Heparin
2000
Deep venous thrombosis: a new task for primary health care A randomised economic study of outpatient and inpatient treatment
2004
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
2000
Venous Thromboembolism
1999
Escala de riesgo de eventos adversos a corto plazo en pacientes con tromboembolia pulmonar
2007
Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
1998
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
1997
Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis.
2003
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
1999
Acute Deep Vein Thrombosis: Early Mobilization Does not Increase the Frequency of Pulmonary Embolism
2001
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism
2003
Vena caval filters: a comprehensive review
2000
Management of Iliofemoral Thrombosis in a Pregnant Patient With Heparin Resistance
1997
Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis
2003
Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis
1999
Outpatient Use of Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity
1999
Bed Rest in Deep Vein Thrombosis and the Incidence of Scintigraphic Pulmonary Embolism
1999
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis
1998
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin
1998
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Home versus in-patient treatment for deep vein thrombosis
2007
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Fixed-dose, Body Weight-independent Subcutaneous LMW Heparin versus Adjusted Dose Unfractionated Intravenous Heparin in the Initial Treatment of Proximal Venous Thrombosis
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
2004
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Low Molecular Weight Heparin versus Acenocoumarol in the Secondary Prophylaxis of Deep Vein Thrombosis
1999
Relation Between the Time to Achieve the Lower Limit of the APTT Therapeutic Range and Recurrent Venous Thromboembolism During Heparin Treatment for Deep Vein Thrombosis
1997
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
1997
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism
2004
Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis
2000
Low-Molecular-Weight Heparin Versus Saphenofemoral Disconnection for the Treatment of Above-Knee Greater Saphenous Thrombophlebitis: A Prospective Study
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism
2003
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis
1999
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
1997
Low-Molecular-Weight Heparins
1997 Standout
Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation
1998
General Internal Medicine at the Crossroads of Prosperity and Despair: Caring for Patients with Chronic Diseases in an Aging Society
2001
Comparison of Low-Molecular-Weight Heparin, Administered Primarily at Home, with Unfractionated Heparin, Administered in Hospital, and Subcutaneous Heparin, Administered at Home for Deep-Vein Thrombosis
1999
Home versus in-patient treatment for deep vein thrombosis
2018
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
2004
Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism
2014
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
2014
Outpatient Treatment of Pulmonary Embolism with Dalteparin
2000
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
2010
Works of William Brien being referenced
An audit of blood component therapy in a Canadian general teaching hospital.
1989
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
1996
A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty
1997
The antiphospholipid syndrome: Prevalence among patients with stroke and transient ischemic attacks
1990
Prospective validation of a point score system for predicting blood transfusion following hip or knee replacement
1998
Auto‐immune thrombocytopenia related to interferon therapy
1986
Chronic consumptive coagulopathy due to intracardiac thrombus
1987